University Use Sample Clauses

University Use. 9.1 It is expressly agreed that, notwithstanding any provisions herein, University is free to use University Technology, Patent Rights and Licensed Products for its own research, public service, clinical, teaching and educational purposes shall be free without payment of royalties. Furthermore, University shall be free to publish University Technology, as it sees fit.
Sample 1Sample 2See All (4)
AutoNDA by SimpleDocs
University Use. The agreement gives the University the right during the agreement to redistribute Respondus to current employees, instructors, and teaching assistants of the University. Current employees, instructors, and teaching assistants of the University are permitted to use Respondus only for educational or academic purposes. Use of the software for any other purpose (e.g., private consultant services) is prohibited. Current employees, instructors, and teaching assistants of the University have the right to use the Software Product(s) at an off‐campus location (e.g., at home) provided that all use is related to non‐profit educational or academic endeavors for the University. NOTICE TO USERS: CAREFULLY READ THE FOLLOWING LEGAL AGREEMENT. USE OF THE SOFTWARE PROVIDED WITH THE AGREEMENT (THE "SOFTWARE") CONSTITUTES YOUR ACCEPTANCE OF THESE TERMS.
Sample 1
University Use. Subject to the foregoing provisions of this Article V, the University shall have the right to use any non-revenue producing portion of the Convocation Center so long as such use will not conflict with the presentation of Events and the University gives SMG reasonable prior notice of any such intended use.
Sample 1
University Use. 9.1. It is expressly agreed that, notwithstanding any provisions herein, University is free to make noncommercial use of University Technology, Patent Rights and Licensed Products for its own research, public service, clinical, teaching and educational purposes without payment of royalties. Furthermore, University shall be free to publish University Technology, as it sees fit, except that Licensee shall have the right to review any proposed disclosure of University Technology at least sixty (60) days prior to such disclosure to determine whether filing of a patent application covering such disclosure is warranted. If it is determined by Licensee that a patent application should be filed, University shall delay its publication or disclosure for a period not to exceed thirty (30) days thereafter to allow time for the filing of such patent application covering patentable subject matter. All expenses associated with any such patent application are to be borne by Licensee in accordance with Article 10 herein. Such delay, however, shall not be imposed on the filing of any student thesis or dissertation. In addition, if it is determined in good faith by Licensee that confidential or proprietary information is being disclosed, the parties will consult in good faith to arrive at an agreement on mutually acceptable modifications to the proposed disclosure to avoid such disclosure; provided that University shall not be required to make any modification that are not reasonably acceptable to University.
Sample 1
University Use. It is expressly agreed that, notwithstanding any provisions herein, University is free to use the results of the research performed during the Option Exercise period for its own research, public service, clinical, teaching and educational purposes without payment of royalties. Furthermore, University shall be free to publish University Technology, pursuant to Section 6 of the Sponsored Research Agreement and during the Option Exercise Period, as it sees fit.
Sample 1
University Use. It is expressly agreed that, notwithstanding any other provisions herein, University is free to use University Technology, Patents and Licensed Compounds for its own non-commercial research, and clinical, teaching and educational purposes (including distribution of any compounds covered under the Patents to academic collaborators provided that the academic collaborators receiving Licensed Compounds shall be obligated to not transfer the Licensed Compounds to third party commercial entities and to not use the Licensed Compounds in research sponsored by third party commercial entities) without payment of royalties. In no event shall University transfer the Patents or Licensed Compounds for sale or other distribution to third parties other than non-profit research or educational institutions, or to such institutions in contravention of the foregoing provisions. Furthermore, except as otherwise set forth in the Sponsored Research Agreement, University shall be free to publish University Technology as it sees fit. Notwithstanding the foregoing, in no event shall University use, or grant any third party a right to use, any Patents and/or Licensed Compounds in the Licensed Field for commercial purposes during the Term, including, without limitation, conducting sponsored research with any for-profit entity during the Term. It is expressly agreed that, notwithstanding any other provisions herein, Niigata is free to use Niigata Technology, Niigata Patents and Licensed Compounds covered by such Niigata Technology or Niigata Patents solely for its own non-commercial research, and clinical, teaching and educational purposes (including distribution of any compounds covered under the Niigata Patents to academic collaborators provided that the academic collaborators receiving such Licensed Compounds shall be obligated to not transfer such Licensed Compounds to third party commercial entities and to not use such Licensed Compounds in research sponsored by third party commercial entities) without payment of royalties. In no event shall Niigata transfer the Niigata Patents or Licensed Compounds covered by the Niigata Patents or Niigata Technology for sale or other distribution to third parties other than non-profit research or educational institutions, or to such institutions in contravention of the foregoing provisions. Notwithstanding the foregoing, in no event shall Niigata use, or grant any third party a right to use, any Niigata Patents and/or Licensed Compounds covered...
Sample 1
University Use. 9.1. It is expressly agreed that, notwithstanding any provisions herein, Licensor is free to make non-commercial use of University Technology, New Licensed Technology, Patent Rights and Licensed Products for its own internal, not for profit research, teaching and educational purposes without payment of royalties. Furthermore Licensor reserves, on behalf of the Principal Investigator and other Licensor employees and/or students, the right to disseminate or publish University Technology; provided, however, Licensor shall make no such disclosure unless Licensor shall have provided Licensee with a copy of any proposed publication thirty (30) days in advance of the submission by Licensor or any author to a third party of any written materials intended for publication. If the proposed disclosure contains Licensee’s confidential information, Licensor shall remove or cause the author to remove such Licensee confidential information prior to submission for publication or other public disclosure. Licensee may request, and Licensor shall agree to, or shall cause the author to agree to, a delay of such proposed submission for publication for an additional period, not to exceed forty-five (45) days, in order to protect the potential patentability of any invention described therein by having Licensor or Licensee prepare and file a patent application. It is specifically agreed that nothing contained in this Agreement will interfere with the publication or oral defense of research theses and dissertations of graduate students.
Sample 1
AutoNDA by SimpleDocs
University Use. It is expressly agreed that, notwithstanding any other provisions herein, University is free to use University Technology, Patents and Licensed Compounds for its own non-commercial research, and clinical, teaching and educational purposes (including distribution of any compounds covered under the Patents to academic collaborators provided that the academic collaborators receiving Licensed Compounds shall be obligated to not transfer the Licensed Compounds to third party commercial entities and to not use the Licensed Compounds in research sponsored by third party commercial entities) without payment of royalties. In no event shall University transfer the Patents or Licensed Compounds for sale or other distribution to third parties other than non-profit research or educational institutions, or to such institutions in contravention of the foregoing provisions. Furthermore, except as otherwise set forth in the Sponsored Research Agreement, University shall be free to publish University Technology as it sees fit. Notwithstanding the foregoing, in no event shall University use, or grant any third party a right to use, any Patents and/or Licensed Compounds in the Licensed Field for commercial purposes during the Term, including, without limitation, conducting sponsored research with any for-profit entity during the Term. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934.
Sample 1
University Use. It is expressly agreed that, notwithstanding any other provisions herein, University [***] University Technology, Patents and Licensed Compounds for its own non-commercial research, and clinical, teaching and educational purposes (including distribution of any compounds covered under the Patents to academic collaborators provided that the academic collaborators receiving Licensed Compounds shall be obligated to not transfer the Licensed Compounds to third party commercial entities and to not use the Licensed Compounds in research sponsored by third party commercial entities) [***]. In no event shall University transfer the Patents or Licensed Compounds for sale or other distribution to third parties [***] in contravention of the foregoing provisions. Furthermore, except as otherwise set forth in the Sponsored Research Agreement, University [***] to publish University Technology [***]. Notwithstanding the foregoing, in no event shall University use, or grant any third party a right to use, any Patents and/or Licensed Compounds in the Licensed Field for commercial purposes during the Term, including, without limitation, conducting sponsored research with any for-profit entity during the Term.
Sample 1

Related to University Use

  • Licensee Licensee represents and warrants that:

  • Licensor any Person from whom a Grantor obtains the right to use any Intellectual Property. Lien: any Person’s interest in Property securing an obligation owed to, or a claim by, such Person, whether such interest is based on common law, statute or contract, including liens, security interests, pledges, hypothecations, statutory trusts, reservations, exceptions, encroachments, easements, rights-of-way, covenants, conditions, restrictions, leases, and other title exceptions and encumbrances affecting Property. Lien Waiver: an agreement, in form and substance satisfactory to Collateral Agent, by which (a) for any material Collateral located on leased premises, the lessor waives or subordinates any Lien it may have on the Collateral, and agrees to permit Collateral Agent to enter upon the premises and remove the Collateral or to use the premises to store or dispose of the Collateral; (b) for any Collateral held by a warehouseman, processor, shipper, customs broker or freight forwarder, such Person waives or subordinates any Lien it may have on the Collateral, agrees to hold any Documents in its possession relating to the Collateral as agent for Collateral Agent, and agrees to deliver the Collateral to Collateral Agent upon request; (c) for any Collateral held by a repairman, mechanic or bailee, such Person acknowledges Collateral Agent’s Lien, waives or subordinates any Lien it may have on the Collateral, and agrees to deliver the Collateral to Collateral Agent upon request; and (d) for any Collateral subject to a Licensor’s Intellectual Property rights, the Licensor grants to Collateral Agent the right, vis-à-vis such Licensor, to enforce Collateral Agent’s Liens with respect to the Collateral, including the right to dispose of it with the benefit of the Intellectual Property, whether or not a default exists under any applicable License.

  • Licensed Patents Licensee shall be responsible for all further patent prosecution with respect to the Licensed Patents and Licensed Technologies set out in Exhibit “A”. Licensee may select the patent agent for the prosecution of the Licensed Patents, subject to the approval of Licensor as the patent owner, which approval will not be unreasonably withheld. Licensee shall provide Licensor with copies of all relevant documentation related to the filing and prosecution of the Licensed Patents so that Licensor may be informed and apprised of and meaningfully consulted as to the continuing prosecution. Licensor shall keep all such documentation confidential. In the event the Licensee does not agree that any given patent application or patent should be filed, prosecuted or maintained (hereinafter referred to as a “Refused Licensed Patent”) in a particular jurisdiction(s) Licensee shall indicate such disagreement in writing (hereinafter “Refusal Notice”) and upon Licensor’s receipt of such Refusal Notice Licensor shall have the right unilaterally to make, prosecute and maintain such Refused Licensed * Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission Patent in such jurisdiction(s) in the name of its owners, at Licensor’s expense, and Licensee shall not have any rights or obligations to such Refused Licensed Patent in such jurisdiction(s); provided, however, that Licensee shall retain all of its ownership rights in any Refused Licensed Patent that is a Co-Owned Technology. In such case Licensor shall provide Licensee with copies of all relevant documentation related to the filing and prosecution of the Refused Licensed Patents so that Licensee may be informed and apprised of and be meaningfully consulted with as to the continuing prosecution. Licensor shall have no obligation to continue prosecution or maintenance of any Refused Licensed Patent and may abandon same without any prior notice or any obligation to Licensee. Both Licensee and Licensor shall make best efforts to respond promptly to any request from the other Party for input or assistance with respect to matters pertaining to the Licensed Patents. Licensee shall use reasonable efforts to amend any patent application to include claims reasonably requested by the other Party and required to protect the Licensed Technology. In addition to Licensee’s obligations pursuant to section 4.1 above, Licensee shall be solely responsible for all patent and legal costs relating to the Licensed Patents and Licensed Technology (excluding Refused Licensed Patents) from the Effective Date onward, including all costs relating to the transfer of the Licensed Patents to the new patent agents selected by Licensee and approved by Licensor. For any patent and legal costs relating to the Licensed Patents and Licensed Technology (excluding Refused Licensed Patents) paid by Licensor after the Effective Date (including, without limitation, those expenses related to patentability assessments and drafting, filing, prosecution, maintenance, and taxes (the “Patent Costs”)), Licensee shall promptly reimburse Licensor for such Patent Costs upon receipt of an invoice from Licensor for such expenses. For any work in progress with respect to the Licensed Patents for which the Patent Costs have not already been paid by Licensor to its patent firm prior to the transfer of the Licensed Patents to Licensee’s patent agent, Licensor will direct its patent firm to copy Licensee on all such invoices from said patent firm and Licensee will promptly pay said invoices directly to Licensor’s patent firm.

  • Licensor’s Use Nothing in this Agreement shall preclude Licensor, its affiliates, or any of its respective successors or assigns from using or permitting other entities to use the Licensed Name whether or not such entity directly or indirectly competes or conflicts with the Licensee’s business in any manner.

Time is Money Join Law Insider Premium to draft better contracts faster.